Follow
Caroline Perner
Caroline Perner
Research Group leader
Verified email at med.uni-greifswald.de
Title
Cited by
Cited by
Year
Roles of JAK2 in aging, inflammation, hematopoiesis and malignant transformation
F Perner, C Perner, T Ernst, FH Heidel
Cells 8 (8), 854, 2019
1792019
Substance P release by sensory neurons triggers dendritic cell migration and initiates the type-2 immune response to allergens
C Perner, CH Flayer, X Zhu, PA Aderhold, ZNA Dewan, T Voisin, ...
Immunity 53 (5), 1063-1077. e7, 2020
1642020
Time-dependent changes in microglia transcriptional networks following traumatic brain injury
S Izzy, Q Liu, Z Fang, S Lule, L Wu, JY Chung, A Sarro-Schwartz, ...
Frontiers in cellular neuroscience 13, 307, 2019
802019
The CysLT2R receptor mediates leukotriene C4-driven acute and chronic itch
T Voisin, C Perner, MA Messou, S Shiers, S Ualiyeva, Y Kanaoka, ...
Proceedings of the National Academy of Sciences 118 (13), e2022087118, 2021
662021
Disease specific aspects of malnutrition in neurogeriatric patients
T Prell, C Perner
Frontiers in aging neuroscience 10, 80, 2018
472018
Plasma VCAM1 levels correlate with disease severity in Parkinson’s disease
C Perner, F Perner, N Gaur, S Zimmermann, OW Witte, FH Heidel, ...
Journal of neuroinflammation 16, 1-5, 2019
382019
The chitinases as biomarkers for amyotrophic lateral sclerosis: signals from the CNS and beyond
N Gaur, C Perner, OW Witte, J Grosskreutz
Frontiers in Neurology 11, 377, 2020
322020
Specificity of JAK-kinase inhibition determines impact on human and murine T-cell function
F Perner, TM Schnöder, S Ranjan, D Wolleschak, C Ebert, MC Pils, S Frey, ...
Leukemia 30 (4), 991-995, 2016
252016
Protocol for dissection and culture of murine dorsal root ganglia neurons to study neuropeptide release
C Perner, CL Sokol
STAR protocols 2 (1), 100333, 2021
242021
Dysregulation of chemokine receptor expression and function in leukocytes from ALS patients
C Perner, F Perner, B Stubendorff, M Förster, OW Witte, FH Heidel, T Prell, ...
Journal of neuroinflammation 15 (1), 1-5, 2018
242018
Comparison of anonymous versus nonanonymous responses to a medication adherence questionnaire in patients with Parkinson’s disease
T Prell, D Schaller, C Perner, GH Franke, OW Witte, A Kunze, ...
Patient preference and adherence, 151-155, 2019
182019
A decision tree model for neuroimmune guidance of allergic immunity
CH Flayer, C Perner, CL Sokol
Immunology and Cell Biology 99 (9), 936-948, 2021
162021
Expression and function of ABC-transporter protein ABCB1 correlates with inhibitory capacity of Ruxolitinib in vitro and in vivo
C Ebert, F Perner, D Wolleschak, TM Schnöder, T Fischer, FH Heidel
haematologica 101 (3), e81, 2016
162016
Endoplasmic reticulum stress and its role in homeostasis and immunity of central and peripheral neurons
C Perner, E Krüger
Frontiers in Immunology 13, 859703, 2022
152022
Sicca symptoms in Parkinson’s disease: association with other nonmotor symptoms and health-related quality of life
T Prell, D Schaller, C Perner, OW Witte, J Grosskreutz
Parkinson’s Disease 2020, 2020
102020
Phenotypic screen identifies the natural product silymarin as a novel anti-inflammatory analgesic
DM DuBreuil, X Lai, K Zhu, G Chahyadinata, C Perner, BM Chiang, ...
Molecular Pain 19, 17448069221148351, 2023
52023
Einfluss von ABC-Transportern auf die Sensitivität von T-Zellen gegenüber dem Janus-Kinase-Inhibitor Ruxolitinib
C Ebert
Otto-von-Guericke-Universität Magdeburg, 2016
2016
The system can't perform the operation now. Try again later.
Articles 1–17